Gasparian Marine E, Ostapchenko Valeriy G, Schulga Alexey A, Dolgikh Dmitry A, Kirpichnikov Mikhail P
Laboratory of Protein Engineering, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, RAS, 16/10 Miklukho-Maklaya, 117997 GSP, Moscow, Russia.
Protein Expr Purif. 2003 Sep;31(1):133-9. doi: 10.1016/s1046-5928(03)00159-1.
Enteropeptidase (synonym:enterokinase, EC 3.4.21.9) is a heterodimeric serine protease of the intestinal brush border that activates trypsinogen by highly specific cleavage of the trypsinogen activation peptide following the sequence (Asp)(4)-Lys. The DNA sequence encoding the light chain (catalytic subunit) of human enteropeptidase (GenBank Accession No. U09860) was synthesized from 26 oligonucleotides by polymerase chain reaction and cloned into plasmid pET-32a downstream to the gene of fusion partner thioredoxin immediately after the DNA sequence encoding enteropeptidase recognition site. The fusion protein thioredoxin/human enteropeptidase light chain was expressed in Escherichia coli BL21(DE3) strain in both soluble and insoluble forms. The soluble recombinant fusion protein failed to undergo autocatalytic cleavage and activation; however, autocatalytic cleavage and activation of recombinant human enteropeptidase light chain (L-HEP) were achieved by solubilization and renaturation of the fusion protein from inclusion bodies and the active L-HEP was purified on agarose-linked soybean trypsin inhibitor. The purified L-HEP cleaved the synthetic peptide substrate Gly-Asp-Asp-Asp-Asp-Lys-beta-naphthylamide with kinetic parameters K(m)=0.16 mM and k(cat)=115 s(-1) and small ester Z-Lys-SBzl with K(m)=140 microM, k(cat)=133 s(-1). L-HEP associated with soybean trypsin inhibitor slowly and small ester Z-Lys-SBzl cleavage was inhibited with K(i)(*)=2.3 nM. L-HEP digested thioredoxin/human epidermal growth factor fusion protein five times faster than equal activity units of bovine recombinant light chain (EKMax, Invitrogen) at the same conditions.
肠肽酶(同义词:肠激酶,EC 3.4.21.9)是一种位于肠刷状缘的异二聚体丝氨酸蛋白酶,通过在序列(天冬氨酸)(4)-赖氨酸之后高度特异性地切割胰蛋白酶原激活肽来激活胰蛋白酶原。编码人肠肽酶轻链(催化亚基)的DNA序列(基因库登录号U09860)通过聚合酶链反应由26个寡核苷酸合成,并在编码肠肽酶识别位点的DNA序列之后,克隆到融合伴侣硫氧还蛋白基因下游的质粒pET-32a中。硫氧还蛋白/人肠肽酶轻链融合蛋白在大肠杆菌BL21(DE3)菌株中以可溶性和不溶性两种形式表达。可溶性重组融合蛋白未能进行自催化切割和激活;然而,通过从包涵体中溶解和复性融合蛋白实现了重组人肠肽酶轻链(L-HEP)的自催化切割和激活,并且活性L-HEP在琼脂糖偶联的大豆胰蛋白酶抑制剂上进行了纯化。纯化后的L-HEP切割合成肽底物甘氨酸-天冬氨酸-天冬氨酸-天冬氨酸-天冬氨酸-赖氨酸-β-萘酰胺,动力学参数为K(m)=0.16 mM,k(cat)=115 s(-1),以及切割小分子酯Z-赖氨酸-SBzl,K(m)=140 microM,k(cat)=133 s(-1)。L-HEP与大豆胰蛋白酶抑制剂的结合缓慢,小分子酯Z-赖氨酸-SBzl的切割受到抑制,K(i)(*)=2.3 nM。在相同条件下,L-HEP消化硫氧还蛋白/人表皮生长因子融合蛋白的速度比相同活性单位的牛重组轻链(EKMax,Invitrogen)快五倍。